Under active development. Data is being added and corrected on an hourly basis.

← Back to Peptides
HGH structure

HGH

growth_hormone
Approved Research
100%
Moderate Risk
3/5

Dosing Protocol

Typical Dose 2 IU
Range 1 - 8 IU
Maintenance 2 IU daily

Pharmacokinetics

Half-Life 3.0 hrs
Onset 1.0 hrs
Peak 4.0 hrs
Duration 1.0 days
Bioavailability 75%
Primary Route Subcutaneous

Administration

Routes Subcutaneous, Intramuscular
Injection Sites Abdomen, Thigh, Deltoid
Needle Gauge 29-31G
Syringe Type Insulin
Timing Morning, Before Bed

Special Instructions

Split doses for better results (morning + pre-bed). Start low, titrate up. Monitor IGF-1 levels.